Literature DB >> 19144778

Dual roles of tumor necrosis factor-alpha receptor-1 in a mouse model of hindlimb ischemia.

Jun Jiang1, Jianan Wang, Changling Li, Shan Ping Yu, Ling Wei.   

Abstract

Signals in the tumor necrosis factor alpha (TNF-alpha) pathway are upregulated after ischemia, yet its role in peripheral ischemia remains unclear. We investigated the effect of TNF-alpha receptor 1 (TNFR-1) in acute limb ischemia of TNFR-1 knockout (TNFR-1-/-) and wild type (WT, TNFR-1+/+) mice. Laser Doppler scanning showed that although pre-ischemia blood flow levels were similar in these mice, the limb reperfusion after ischemia was significantly higher in TNFR-1-/- mice 1-7 days after injury. Consistently, fewer TUNEL-positive cells, less DNA fragmentation, and a lower ischemic score were detected in the TNFR-1-/- group when compared to WT controls. Western blot analysis revealed less expression of pro-apoptotic markers Bax and cleaved caspase-3 in TNFR-1-/- mice 1 day after ischemia, supporting the hypothesis that the absence of TNFR-1 results in a reduction of apoptosis. The rate of post-ischemia amputation was 50% in WT mice versus 0% in TNFR-1-/- mice. However, immunohistochemical co-staining of microvessel marker CD31 and cellular proliferation marker BrdU 21 days after ischemia showed an impaired angiogenic activity in the TNFR-1-/- mice. These data were supported by Western blot analysis, which indicated a decreased expression of angiopoietin-1 (Ang-1) and its receptor Tie-2 in TNFR-1-/- mice. Our results suggest that a deficiency in TNFR-1 prevents the activation of death-related proteins downstream to TNF-alpha and attenuates apoptosis in acute limb ischemia, but the lack of TNFR-1 signaling hinders the belated angiogenesis mediated by the Ang-1/Tie-2 pathway.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19144778      PMCID: PMC3107068          DOI: 10.1177/1358863X08098143

Source DB:  PubMed          Journal:  Vasc Med        ISSN: 1358-863X            Impact factor:   3.239


  39 in total

1.  Lovastatin and tumor necrosis factor-alpha exhibit potentiated antitumor effects against Ha-ras-transformed murine tumor via inhibition of tumor-induced angiogenesis.

Authors:  W Feleszko; E Z Bałkowiec; E Sieberth; M Marczak; A Dabrowska; A Giermasz; A Czajka; M Jakóbisiak
Journal:  Int J Cancer       Date:  1999-05-17       Impact factor: 7.396

2.  Nitric oxide mediates angiogenesis induced in vivo by platelet-activating factor and tumor necrosis factor-alpha.

Authors:  G Montrucchio; E Lupia; A de Martino; E Battaglia; M Arese; A Tizzani; F Bussolino; G Camussi
Journal:  Am J Pathol       Date:  1997-08       Impact factor: 4.307

Review 3.  Cell death induction by TNF: a matter of self control.

Authors:  D Wallach
Journal:  Trends Biochem Sci       Date:  1997-04       Impact factor: 13.807

4.  Angiopoietin-1 induces sprouting angiogenesis in vitro.

Authors:  T I Koblizek; C Weiss; G D Yancopoulos; U Deutsch; W Risau
Journal:  Curr Biol       Date:  1998-04-23       Impact factor: 10.834

5.  Tumor necrosis factor-alpha. A mediator of focal ischemic brain injury.

Authors:  F C Barone; B Arvin; R F White; A Miller; C L Webb; R N Willette; P G Lysko; G Z Feuerstein
Journal:  Stroke       Date:  1997-06       Impact factor: 7.914

6.  Angiopoietin-1 and its receptor Tie-2 participate in the regulation of capillary-like tubule formation and survival of endothelial cells.

Authors:  A J Hayes; W Q Huang; J Mallah; D Yang; M E Lippman; L Y Li
Journal:  Microvasc Res       Date:  1999-11       Impact factor: 3.514

7.  Direct actions of angiopoietin-1 on human endothelium: evidence for network stabilization, cell survival, and interaction with other angiogenic growth factors.

Authors:  A Papapetropoulos; G García-Cardeña; T J Dengler; P C Maisonpierre; G D Yancopoulos; W C Sessa
Journal:  Lab Invest       Date:  1999-02       Impact factor: 5.662

8.  Tie2 receptor ligands, angiopoietin-1 and angiopoietin-2, modulate VEGF-induced postnatal neovascularization.

Authors:  T Asahara; D Chen; T Takahashi; K Fujikawa; M Kearney; M Magner; G D Yancopoulos; J M Isner
Journal:  Circ Res       Date:  1998-08-10       Impact factor: 17.367

Review 9.  Apoptotic, non-apoptotic, and anti-apoptotic pathways of tumor necrosis factor signalling.

Authors:  G Natoli; A Costanzo; F Guido; F Moretti; M Levrero
Journal:  Biochem Pharmacol       Date:  1998-10-15       Impact factor: 5.858

Review 10.  Tumor necrosis factor in the heart.

Authors:  D R Meldrum
Journal:  Am J Physiol       Date:  1998-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.